NeurAxis Announces Medical Policy Coverage Milestone, Expanding Access to 26 Million Additional Covered Lives
NeurAxis won new medical policy coverage for its PENFS IB-Stim therapy from a major national health insurer, adding approximately 26 million covered lives across multiple states. The company says its national coverage footprint now exceeds 147 million lives, and it is expanding its commercial organization under new Chief Commercial Officer Craig Blanchard to convert coverage into utilization.
Key figures
- New covered lives
- 26000000
- Total coverage footprint
- exceeding 147 million lives
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.